Penumbra, Inc. (PEN) Social Stream



Penumbra, Inc. (PEN): $187.78

0.22 (-0.12%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

PENUMBRA INC (PEN) Price Targets From Analysts

Use the tables below to see what analysts covering PENUMBRA INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 6 $350 $204 $303.666 $258.15 17.63%
2021-11-05 7 $350 $204 $302.428 $258.15 17.15%
2022-02-17 6 $350 $308 $323.6 $258.15 25.35%
2022-02-23 5 $308 $300 $302.666 $258.15 17.24%
2022-04-29 5 $308 $250 $289.5 $258.15 12.14%
2022-05-04 6 $308 $250 $289.5 $258.15 12.14%
2022-05-05 6 $308 $240 $261.6 $258.15 1.34%
2022-05-17 5 $308 $220 $254.666 $258.15 -1.35%
2022-08-05 7 $265 $163 $211.571 $258.15 -18.04%
2022-08-08 8 $265 $163 $200 $258.15 -22.53%
2022-09-13 8 $265 $163 $210.444 $258.15 -18.48%
2022-09-19 8 $265 $163 $213.333 $258.15 -17.36%
2022-10-05 9 $265 $163 $213 $258.15 -17.49%
2022-10-12 10 $265 $163 $214.7 $258.15 -16.83%
2022-10-28 10 $265 $175 $218.6 $258.15 -15.32%
2022-10-31 10 $265 $189 $223.1 $258.15 -13.58%
2022-11-04 10 $265 $189 $223.1 $258.15 -13.58%
2022-11-07 11 $244 $167 $202.9 $258.15 -21.4%
2022-11-14 11 $235 $167 $206.8 $258.15 -19.89%
2022-12-05 11 $240 $167 $210.4 $258.15 -18.5%
2022-12-12 11 $270 $167 $219.2 $258.15 -15.09%
2022-12-13 11 $270 $185 $227.9 $258.15 -11.72%
2023-01-03 11 $270 $185 $230.6 $258.15 -10.67%
2023-01-05 11 $270 $185 $235.4 $258.15 -8.81%
2023-01-30 12 $275 $185 $241.727 $258.15 -6.36%
2023-01-31 12 $284 $185 $244.363 $258.15 -5.34%
2023-02-01 12 $285 $185 $247.181 $258.15 -4.25%
2023-02-24 12 $300 $195 $267.454 $258.15 3.6%
2023-03-17 12 $303 $215 $280 $258.15 8.46%
2023-03-28 12 $320 $215 $283.272 $258.15 9.73%
2023-05-02 12 $320 $215 $286.09 $258.15 10.82%
2023-05-03 12 $325 $300 $310.545 $258.15 20.3%
2023-05-18 12 $350 $300 $313.272 $258.15 21.35%
2023-05-24 12 $350 $300 $316.454 $258.15 22.59%
2023-06-05 12 $350 $300 $317.909 $258.15 23.15%
2023-06-27 12 $367 $300 $321.727 $258.15 24.63%
2023-07-10 12 $390 $300 $329.636 $258.15 27.69%
2023-07-12 12 $390 $300 $333.818 $258.15 29.31%
2023-07-17 13 $390 $300 $335.909 $258.15 30.12%
2023-08-02 13 $390 $300 $340.833 $258.15 32.03%
2023-09-06 13 $390 $300 $337.75 $258.15 30.83%
2023-09-08 14 $390 $300 $337.75 $258.15 30.83%
2023-10-04 14 $390 $265 $332.153 $258.15 28.67%
2023-10-13 14 $375 $265 $326.769 $258.15 26.58%
2023-11-03 14 $375 $240 $301.769 $258.15 16.9%
2023-12-12 14 $375 $207 $287.538 $258.15 11.38%
2023-12-20 14 $375 $207 $289.461 $258.15 12.13%
2023-12-22 14 $375 $207 $292.846 $258.15 13.44%
2023-12-29 14 $375 $207 $295.153 $258.15 14.33%

The Trend in the Analyst Price Target


PEN's average price target has moved down $23.54 over the prior 74 days.

PEN reports an average of 27.42% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-01 12 285 185 247.181 257.30 -3.93%
2023-08-18 13 390 300 337.750 251.22 34.44%
2023-09-20 14 390 265 332.153 262.43 26.57%
2023-10-09 14 375 265 326.769 223.07 46.49%
2023-10-10 14 375 265 326.769 232.90 40.3%

PEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.36 11 1 2 0 0 14

The Trend in the Broker Recommendations


Over the past 26 weeks, PEN's average broker recommendation rating worsened by 0.11.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PEN as an investment opportunity.

  • PEN has a greater average analyst price target than 5576.79% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, PENUMBRA INC's upside potential (average analyst target price relative to current price) is greater than 1149.12% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, PENUMBRA INC's variance in analysts' estimates is lower than -1619.98% of them.
  • In terms of how PENUMBRA INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 3745.17% of that group.

In the Medical Equipment industry, NVCR, PODD, and DXCM are the three stocks most similar to PENUMBRA INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding PEN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!